Head and Neck Squamous Cell Carcinoma Trials in France, 2026
Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.
About this register
This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,714 studies in total at the last sync on 11 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.
This page shows the 11 of those studies listing the condition Head and Neck Squamous Cell Carcinoma.
How many Head and Neck Squamous Cell Carcinoma trials are recruiting in France?
2 of the 11 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 9 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.
Summary by phase
| Phase | Studies | Recruiting | Share |
|---|---|---|---|
| Phase 3 | 4 | 0 | 36.4% |
| Phase 2 | 3 | 1 | 27.3% |
| Phase 1/2 | 2 | 1 | 18.2% |
| Phase 1 | 1 | 0 | 9.1% |
| Phase 2/3 | 1 | 0 | 9.1% |
Most active sponsors
| Lead sponsor | Studies | Recruiting |
|---|---|---|
| Genmab | 2 | 0 |
| Groupe Oncologie Radiotherapie Tete et Cou | 2 | 0 |
| Gustave Roussy, Cancer Campus, Grand Paris | 2 | 1 |
| Alentis Therapeutics AG | 1 | 1 |
| Boehringer Ingelheim | 1 | 0 |
| Exelixis | 1 | 0 |
| Gilead Sciences | 1 | 0 |
| Ipsen | 1 | 0 |